As legalizing and decriminalizing marijuana becomes increasingly common among U.S. states, many are left wondering: Is smoking pot actually harmful to developing brains? The claim: Smoking marijuana does not make teenagers stupid, concludes a study in the current Proceedings of the National Academy of Sciences, contrary to other research that

Alzheimer’s disease affects over 5 million U.S. citizens. And as we previously reported, cannabis could play a vital role in respect to delaying the disease’s effects, and also has the potential to terminate it entirely. Now, another new study has concluded that medical cannabis oil is a safe and effective treatment

Could the very plant that for decades was accused of “frying” users’ brains be far superior to pharmaceuticals in treating the “incurable” neurodegenerative condition known as Parkinson’s disease? Despite the political controversy surrounding medical marijuana use in the country, research has begun to emerge showing that a component of this

Cancer is a collection of related diseases involving the abnormal growth of cells within the body. When malignant, cancerous cells divide and spread into surrounding tissues — sometimes at an alarming rate. Many types of cancer result in tumors, which are solid masses of tissue. In the United States, cancer claims the lives of nearly 600,000 people

Certain chemicals in marijuana may kill cancer cells, shrink tumors and prevent the formation of blood vessels that feed tumors. That’s the National Cancer Institute reporting findings from preclinical trials — the kind of research that typically leads to more in-depth testing. But nearly a half-century ago the folks who

The press reports on the JAMA meta-analysis of cannabinoid research were all over the place. Most of them missed the story. Judging from the disparate media headlines, last week’s meta-analysis of cannabinoid research published in the Journal of the American Medical Association (JAMA) contained something for everyone. Here’s a sampling

Marijuana and its use has been studied over the course of the last few decades more so than even many leading FDA-approved pharmaceutical drugs, with researchers categorizing the effects of marijuana to a much greater degree than many of the pharmaceutical drugs you or your family may currently be taking.

A new Cannabis and Cannabinoid Research Journal is on the way.  It is scheduled to be launched in fall 2015. Cannabis and Cannabinoid Research, a new peer-reviewed, open access journal from Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com/), is the only journal dedicated to the scientific, medical, and psychosocial exploration of

While medical cannabis is often used to ease pain or nausea, an Israeli-American biopharmaceutical company is developing medicines containing cannabinoids — chemical compounds from cannabis plants — to treat conditions including diabetes, inflammatory diseases (like arthritis, atherosclerosis and ulcerative colitis) and cardiovascular disorders. ISA Scientific plans a Phase 2 trial

Here is a link to a huge collection of CBD Research findings, organized by condition.   Conditions listed include: General Acne ADD/ADHD Addiction AIDS ALS Alzheimer’s Anorexia Antibiotic resistance Anxiety Atherosclerosis Arthritis Asthma Autism Bipolar Cancer Colitis/Crohn’s Depression Diabetes Endocrine disorders Epilepsy/seizure Fibromyalgia Glaucoma Heart disease Huntington’s Inflammation Irritable bowel Kidney